These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 26096778

  • 1. Prenatal exposure to H2 blockers and to proton pump inhibitors and asthma development in offspring.
    Yitshak-Sade M, Gorodischer R, Aviram M, Novack L.
    J Clin Pharmacol; 2016 Jan; 56(1):116-23. PubMed ID: 26096778
    [Abstract] [Full Text] [Related]

  • 2. Exposure to acid-suppressing drugs during pregnancy and the risk of asthma in childhood: an observational cohort study.
    Cea Soriano L, Hernández-Díaz S, Johansson S, Nagy P, García-Rodríguez LA.
    Aliment Pharmacol Ther; 2016 Feb; 43(3):427-37. PubMed ID: 26612701
    [Abstract] [Full Text] [Related]

  • 3. Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study.
    Andersen AB, Erichsen R, Farkas DK, Mehnert F, Ehrenstein V, Sørensen HT.
    Aliment Pharmacol Ther; 2012 May; 35(10):1190-8. PubMed ID: 22443179
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prenatal exposure to acid-suppressive drugs and the risk of allergic diseases in the offspring: a cohort study.
    Mulder B, Schuiling-Veninga CC, Bos HJ, De Vries TW, Jick SS, Hak E.
    Clin Exp Allergy; 2014 Feb; 44(2):261-9. PubMed ID: 24164287
    [Abstract] [Full Text] [Related]

  • 8. Prenatal exposure to acid-suppressant medications and the risk of recurrent wheeze at 3 years of age in children with a history of severe bronchiolitis.
    Robinson LB, Chen Arroyo AJ, Dantas MAS, Espinola JA, Sullivan AF, Camargo CA.
    J Allergy Clin Immunol Pract; 2019 Feb; 7(7):2422-2424.e4. PubMed ID: 30878709
    [No Abstract] [Full Text] [Related]

  • 9. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
    Cohen S, Bueno de Mesquita M, Mimouni FB.
    Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
    Sakurada T, Kawashima J, Ariyama S, Kani K, Takabayashi H, Ohno S, Kato S, Yakabi K.
    Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Gastric Acid Suppressant Prophylaxis in Pediatric Intensive Care: Current Practice as Reflected in a Large Administrative Database.
    Costarino AT, Dai D, Feng R, Feudtner C, Guevara JP.
    Pediatr Crit Care Med; 2015 Sep; 16(7):605-12. PubMed ID: 25901549
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison tables: H2-receptor antagonists and PPIs.
    Med Lett Drugs Ther; 2022 Apr 04; 64(1647):e56-e57. PubMed ID: 35348553
    [No Abstract] [Full Text] [Related]

  • 20. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
    Tofil NM, Benner KW, Fuller MP, Winkler MK.
    J Crit Care; 2008 Sep 04; 23(3):416-21. PubMed ID: 18725049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.